News Preview
Cellectar Biosciences, Inc. (CLRB) Q3 2026 Earnings Call Transcript
Cellectar Biosciences, Inc. (CLRB) reported Q3 2026 earnings, with revenue up 10% year-over-year. The company also provided an update on its cancer treatment pipeline.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.